These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 11001931)
1. Alzheimer's disease-associated presenilin 2 interacts with DRAL, an LIM-domain protein. Tanahashi H; Tabira T Hum Mol Genet; 2000 Sep; 9(15):2281-9. PubMed ID: 11001931 [TBL] [Abstract][Full Text] [Related]
2. Calsenilin is a substrate for caspase-3 that preferentially interacts with the familial Alzheimer's disease-associated C-terminal fragment of presenilin 2. Choi EK; Zaidi NF; Miller JS; Crowley AC; Merriam DE; Lilliehook C; Buxbaum JD; Wasco W J Biol Chem; 2001 Jun; 276(22):19197-204. PubMed ID: 11278424 [TBL] [Abstract][Full Text] [Related]
3. Mapping the APP/presenilin (PS) binding domains: the hydrophilic N-terminus of PS2 is sufficient for interaction with APP and can displace APP/PS1 interaction. Pradier L; Carpentier N; Delalonde L; Clavel N; Bock MD; Buée L; Mercken L; Tocqué B; Czech C Neurobiol Dis; 1999 Feb; 6(1):43-55. PubMed ID: 10078972 [TBL] [Abstract][Full Text] [Related]
4. RNA interference silencing of DRAL affects processing of amyloid precursor protein. Tanahashi H; Yoshioka K Neurosci Lett; 2008 Jul; 439(3):293-7. PubMed ID: 18534756 [TBL] [Abstract][Full Text] [Related]
5. Isolation of human delta-catenin and its binding specificity with presenilin 1. Tanahashi H; Tabira T Neuroreport; 1999 Feb; 10(3):563-8. PubMed ID: 10208590 [TBL] [Abstract][Full Text] [Related]
6. Brain expression of presenilins in sporadic and early-onset, familial Alzheimer's disease. Mathews PM; Cataldo AM; Kao BH; Rudnicki AG; Qin X; Yang JL; Jiang Y; Picciano M; Hulette C; Lippa CF; Bird TD; Nochlin D; Walter J; Haass C; Lévesque L; Fraser PE; Andreadis A; Nixon RA Mol Med; 2000 Oct; 6(10):878-91. PubMed ID: 11126202 [TBL] [Abstract][Full Text] [Related]
7. The presenilin 2 loop domain interacts with the mu-calpain C-terminal region. Shinozaki K; Maruyama K; Kume H; Tomita T; Saido TC; Iwatsubo T; Obata K Int J Mol Med; 1998 May; 1(5):797-9. PubMed ID: 9852298 [TBL] [Abstract][Full Text] [Related]
8. DRAL is a p53-responsive gene whose four and a half LIM domain protein product induces apoptosis. Scholl FA; McLoughlin P; Ehler E; de Giovanni C; Schäfer BW J Cell Biol; 2000 Oct; 151(3):495-506. PubMed ID: 11062252 [TBL] [Abstract][Full Text] [Related]
9. The LIM-only protein DRAL/FHL2 binds to the cytoplasmic domain of several alpha and beta integrin chains and is recruited to adhesion complexes. Wixler V; Geerts D; Laplantine E; Westhoff D; Smyth N; Aumailley M; Sonnenberg A; Paulsson M J Biol Chem; 2000 Oct; 275(43):33669-78. PubMed ID: 10906324 [TBL] [Abstract][Full Text] [Related]
10. A myristoylated calcium-binding protein that preferentially interacts with the Alzheimer's disease presenilin 2 protein. Stabler SM; Ostrowski LL; Janicki SM; Monteiro MJ J Cell Biol; 1999 Jun; 145(6):1277-92. PubMed ID: 10366599 [TBL] [Abstract][Full Text] [Related]
11. Subtractive cloning and characterization of DRAL, a novel LIM-domain protein down-regulated in rhabdomyosarcoma. Genini M; Schwalbe P; Scholl FA; Remppis A; Mattei MG; Schäfer BW DNA Cell Biol; 1997 Apr; 16(4):433-42. PubMed ID: 9150430 [TBL] [Abstract][Full Text] [Related]
12. Stable association of presenilin derivatives and absence of presenilin interactions with APP. Thinakaran G; Regard JB; Bouton CM; Harris CL; Price DL; Borchelt DR; Sisodia SS Neurobiol Dis; 1998 Apr; 4(6):438-53. PubMed ID: 9666482 [TBL] [Abstract][Full Text] [Related]
13. The LIM-only protein DRAL/FHL2 interacts with and is a corepressor for the promyelocytic leukemia zinc finger protein. McLoughlin P; Ehler E; Carlile G; Licht JD; Schäfer BW J Biol Chem; 2002 Oct; 277(40):37045-53. PubMed ID: 12145280 [TBL] [Abstract][Full Text] [Related]
14. The influence of endoproteolytic processing of familial Alzheimer's disease presenilin 2 on abeta42 amyloid peptide formation. Jacobsen H; Reinhardt D; Brockhaus M; Bur D; Kocyba C; Kurt H; Grim MG; Baumeister R; Loetscher H J Biol Chem; 1999 Dec; 274(49):35233-9. PubMed ID: 10575009 [TBL] [Abstract][Full Text] [Related]
15. Biochemical properties of endogenous presenilin 1 and presenilin 2 in cultured human B-lymphocytes. Bojarski L; Lewandowicz A; Blazejczyk M; Sobczak A; Kuznicki J; Wojda U Clin Chem Lab Med; 2007; 45(10):1273-6. PubMed ID: 17663636 [TBL] [Abstract][Full Text] [Related]
16. Mutational analysis of intrinsic regions of presenilin 2 that determine its endoproteolytic cleavage and pathological function. Shirotani K; Takahashi K; Araki W; Maruyama K; Tabira T J Biol Chem; 2000 Feb; 275(5):3681-6. PubMed ID: 10652366 [TBL] [Abstract][Full Text] [Related]
17. Subcellular targeting of metabolic enzymes to titin in heart muscle may be mediated by DRAL/FHL-2. Lange S; Auerbach D; McLoughlin P; Perriard E; Schäfer BW; Perriard JC; Ehler E J Cell Sci; 2002 Dec; 115(Pt 24):4925-36. PubMed ID: 12432079 [TBL] [Abstract][Full Text] [Related]
18. Calsenilin: a calcium-binding protein that interacts with the presenilins and regulates the levels of a presenilin fragment. Buxbaum JD; Choi EK; Luo Y; Lilliehook C; Crowley AC; Merriam DE; Wasco W Nat Med; 1998 Oct; 4(10):1177-81. PubMed ID: 9771752 [TBL] [Abstract][Full Text] [Related]
19. Determination of a cleavage site of presenilin 2 protein in stably transfected SH-SY5Y human neuroblastoma cell lines. Shirotani K; Takahashi K; Ozawa K; Kunishita T; Tabira T Biochem Biophys Res Commun; 1997 Nov; 240(3):728-31. PubMed ID: 9398634 [TBL] [Abstract][Full Text] [Related]
20. Studies of the role of ubiquitination in the interaction of ubiquilin with the loop and carboxyl terminal regions of presenilin-2. Ford DL; Monteiro MJ Biochemistry; 2007 Jul; 46(30):8827-37. PubMed ID: 17614368 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]